Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Two Doses of WRAIR Live Attenuated Tetravalent Dengue Vaccine Formulations, Administered Six Months Apart, to Healthy Adults and Children.
Phase of Trial: Phase II
Latest Information Update: 03 Mar 2016
At a glance
- Drugs TDENV LAV (Primary)
- Indications Dengue
- Focus Adverse reactions; Pharmacodynamics
- 13 Jan 2011 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
- 13 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jan 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.